Literature DB >> 6372410

Iohexol versus metrizamide for lumbar myelography: double-blind trial.

T O Gabrielsen, S S Gebarski, J E Knake, J T Latack, P J Yang, J T Hoff.   

Abstract

Lumbar myelography was performed in 50 patients; 25 received iohexol (an investigational aqueous contrast agent) and 25 received metrizamide. The two media produced radiographs of equal quality. However, iohexol is stable in solution, while metrizamide is not. Further, markedly less morbidity resulted from iohexol. These features indicate that iohexol may be superior to metrizamide as a contrast agent for lumbar myelography.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6372410     DOI: 10.2214/ajr.142.5.1047

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  2 in total

1.  Which factors affect reported headache incidences after lumbar myelography? A statistical analysis of publications in the literature.

Authors:  T Sand
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

2.  Side effects after ambulatory lumbar iohexol myelography.

Authors:  T Sand; G Myhr; L J Stovner; L G Dale; A Tangerud
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.